Descending thoracic aortic syndromes : Initial experience with the endovascular treatment at King Hussein Medical Center

الملخص EN

To study the outcomes of thoracic endovascular aortic stenting for a variety of descending thoracic aortic pathologies at King Hussein Medical Center and to compare outcomes with other multi-institutional centers.

Methods: The charts of patients who had thoracic endovascular aortic stenting at King Hussein Medical Center in the period between January 2012 and December 2013 were reviewed.

31 patients (28 males), in the age range of 23-77 years (mean 56.6 years).

7 patients had the endovascular procedure for acute type B descending aortic dissection, while 19 patients had the procedure for aneurysmal disease, and the remainder 5 patients had stenting for traumatic transection.

Endpoints included are: Early mortality, stroke, endoleak, myocardial infarction, spinal cord ischemia and groin vascular complications.

The mean follow up period was 180 days.

All adult patients who had descending thoracic aortic syndromes and have thoracic endovascular aortic stenting performed were included.

Patients with marfan syndrome were excluded from the study group.

Results: One out of thirty one patients developed early postoperative stroke, with complete recovery, the average in-hospital stay was 3.4 days.

2 patients developed vascular complications in the groin vessels related to the endovascular procedure, and were managed successfully.

2 patients had early mortality, while 2 patients had spinal cord ischemia.

1 patient had endo-leak during their follow up period.

Conclusion: Thoracic endovascular aortic stenting is a viable therapeutic option in descending thoracic aortic pathologies and can be performed safely with minimal risks.